Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
Summary of Consolidated Financial Results for the Year Ended March 31, 2025 [Japanese GAAP]
Company name: Kyosan Electric Manufacturing Co.,Ltd. Listing: Tokyo Stock Exchange
Securities code: 6742
URL: https://www.kyosan.co.jp
Representative: Ryoji Kunisawa Representative Director, President
Inquiries: Aki Sato Financial Management Headquarters
May 14, 2025
General Manager of Finance & Accounting Dept.
Telephone: +81-45-503-8106
Scheduled date of annual general meeting of shareholders: June 25, 2025 Scheduled date to commence dividend payments: June 26, 2025 Scheduled date to file annual securities report: June 24, 2025
Preparation of supplementary material on financial results: Yes Holding of financial results briefing: Yes
(Yen amounts are rounded down to millions, unless otherwise noted.)
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (April 1, 2024 to March 31, 2025)
(1) Consolidated Operating Results (Percentages indicate year-on-year changes.)
Net sales
Operating profit
Ordinary profit
Profit attributable to owners of parent
Fiscal year ended
March 31, 2025
March 31, 2024
Millions of yen
85,367
70,525
%
21.0
(2.5)
Millions of yen
6,112
2,491
%
145.3
12.9
Millions of yen
6,646
3,259
%
103.9
21.5
Millions of yen
4,783
3,434
%
39.3
65.8
(Note) Comprehensive income:
Fiscal year ended March 31, 2025:
¥
3,318 million
[
(26.8) %]
Fiscal year ended March 31, 2024:
¥
4,531 million
[
87.4%]
Basic earnings per share
Diluted earnings per share
Rate of return on equity
Ordinary profit to total assets ratio
Operating profit to net sales ratio
Fiscal year ended
Yen
Yen
%
%
%
March 31, 2025
76.28
-
9.4
5.2
7.2
March 31, 2024
54.76
-
7.2
2.7
3.5
(Reference) Equity in earnings (losses) of affiliated companies:
Fiscal year ended March 31, 2025:
¥
466 million
(2) Consolidated Financial Position
Fiscal year ended March 31, 2024:
¥
348 million
Total assets
Net assets
Capital adequacy ratio
Net assets per share
As of
March 31, 2025
March 31, 2024
Millions of yen
126,005
129,563
Millions of yen
51,711
49,647
%
41.0
38.3
Yen
824.52
791.61
(Reference) Equity: As of March 31, 2025:
¥
51,711 million
As of March 31, 2024:
¥
49,647 million
(3) Consolidated Cash Flows
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash
equivalents at the end of period
Fiscal year ended March 31, 2025
March 31, 2024
Millions of yen
3,743
(5,905)
Millions of yen
(317)
1,717
Millions of yen
(4,452)
7,407
Millions of yen
8,132
9,183
Dividends
Annual dividends
Total dividends
Payout ratio (consolidated)
Dividends to net assets (consolidated)
1st quarter-end
2nd quarter-end
3rd quarter-end
Year-end
Total
Fiscal year ended March 31, 2024
March 31, 2025
Yen
-
-
Yen
5.00
5.00
Yen
-
-
Yen
15.00
18.00
Yen
20.00
23.00
Millions of yen
1,254
1,443
%
36.5
30.2
%
2.6
2.8
Fiscal year ending March 31, 2026
(Forecast)
-
5.00
-
18.00
23.00
41.2
Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2026 (April 1, 2025 to March 31, 2026)
(Percentages indicate year-on-year changes.)
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | Basic earnings per share | |||||
Millions of yen 30,700 86,000 | % | Millions of yen (1,650) 4,700 | % | Millions of yen (1,350) 5,000 | % | Millions of yen (920) 3,500 | % | Yen | |
Six months ending September 30, 2025 | 17.2 | - | - | - | (14.67) | ||||
Full year | 0.7 | (23.1) | (24.8) | (26.8) | 55.81 | ||||
* Notes:
Significant changes in the scope of consolidation during the period: None
Newly included:
- (Company name:
- )
Excluded:
- (Company name:
- )
Changes in accounting policies, changes in accounting estimates, and restatement
Changes in accounting policies due to revisions to accounting standards and other regulations: None
Changes in accounting policies due to other reasons: None
Changes in accounting estimates: None
Restatement: None
Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares): March 31, 2025: 62,844,251 shares
March 31, 2024: 62,844,251 shares
Number of treasury shares at the end of the period:
March 31, 2025: 127,015 shares
March 31, 2024: 126,963 shares
Average number of shares outstanding during the period:
Fiscal Year ended March 31, 2025: 62,717,254 shares
Fiscal Year ended March 31, 2024: 62,717,326 shares
Financial results reports are exempt from audit conducted by certified public accountants or an audit firm.
Proper use of earnings forecasts, and other special matters
The forecasts and other forward-looking statements in this document are based on information currently available to the Company and certain assumptions deemed to be reasonable.
Actual results may differ materially from these forecasts due to various factors.
Consolidated Financial Statements
Consolidated Balance Sheets
(Millions of yen)
As of March 31, 2024 As of March 31, 2025
Assets
Current assets
Cash and deposits
9,487
8,170
Notes receivable - trade
303
311
Electronically recorded monetary claims -operating
1,376
2,682
Accounts receivable - trade
20,087
21,066
Contract assets
9,952
6,771
Finished goods
4,740
4,889
Semi-finished goods
10,398
11,947
Work in process
34,845
33,364
Raw materials and supplies
513
434
Other
3,167
3,195
Total current assets
94,873
92,833
Non-current assets
Property, plant and equipment
Buildings and structures, net
9,925
9,406
Machinery, equipment and vehicles, net
494
636
Tools, furniture and fixtures, net
1,029
822
Land
2,527
2,527
Leased assets, net
740
604
Construction in progress
156
247
Total property, plant and equipment
14,873
14,245
Intangible assets
566
449
Investments and other assets
Investment securities
13,868
11,991
Deferred tax assets
3,262
4,130
Retirement benefit asset
25
0
Other
2,102
2,363
Allowance for doubtful accounts
(9)
(9)
Total investments and other assets
19,249
18,477
Total non-current assets
34,689
33,171
Total assets
129,563
126,005
(Millions of yen)
As of March 31, 2024 As of March 31, 2025
Liabilities
Current liabilities
Notes and accounts payable - trade
10,313
9,410
Electronically recorded obligations - operating
5,378
3,021
Contract liabilities
14,149
13,786
Short-term borrowings
21,000
15,700
Current portion of long-term borrowings
7,200
5,500
Income taxes payable
2,082
2,482
Provision for bonuses for directors (and other officers)
148
250
Provision for loss on orders received
1,169
1,223
Provision for product warranties
-
95
Other
6,116
6,967
Total current liabilities
67,556
58,437
Non-current liabilities
Long-term borrowings
7,800
11,800
Retirement benefit liability
3,749
3,350
Asset retirement obligations
129
123
Provision for product warranties
48
31
Deferred tax liabilities
3
6
Other
628
543
Total non-current liabilities
12,359
15,855
Total liabilities
79,916
74,293
Net assets
Shareholders' equity
Share capital
6,270
6,270
Capital surplus
4,625
4,625
Retained earnings
32,871
36,400
Treasury shares
(45)
(45)
Total shareholders' equity
43,722
47,251
Accumulated other comprehensive income
Valuation difference on available-for-sale
securities
4,691
3,152
Foreign currency translation adjustment
755
614
Remeasurements of defined benefit plans
478
693
Total accumulated other comprehensive income
5,925
4,460
Total net assets
49,647
51,711
Total liabilities and net assets
129,563
126,005
Consolidated Statements of Income and Comprehensive Income
Consolidated Statements of Income
(Millions of yen)
For the fiscal year
For the fiscal year
ended March 31, 2024
ended March 31, 2025
Net sales
70,525
85,367
Cost of sales
56,232
66,641
Gross profit
14,293
18,725
Selling, general and administrative expenses
Salaries and allowances
3,177
3,454
Bonuses
933
1,254
Provision for bonuses for directors (and other officers)
147
222
Retirement benefit expenses
195
170
Depreciation
392
350
Packing and delivery expenses
1,045
1,186
Provision of allowance for doubtful accounts
(0)
-
Other
5,908
5,974
Total selling, general and administrative expenses
11,801
12,613
Operating profit
2,491
6,112
Non-operating income
Dividend income
185
180
Insurance claim income
188
172
Share of profit of entities accounted for using equity
method
348
466
Foreign exchange gains
86
-
Other
188
208
Total non-operating income
996
1,027
Non-operating expenses
Interest expenses
142
276
Financing expenses
42
71
Foreign exchange losses
-
101
Other
42
43
Total non-operating expenses
228
493
Ordinary profit
3,259
6,646
Extraordinary income
Gain on sale of non-current assets
0
16
Gain on sale of investment securities
1,855
253
Total extraordinary income
1,855
270
Extraordinary losses
Loss on sale and retirement of non-current assets
23
20
Loss on sale of investment securities
-
2
Loss on valuation of shares of subsidiaries and
associates
-
7
Impairment losses
-
29
Total extraordinary losses
23
59
Profit before income taxes
5,092
6,857
(Millions of yen)
For the fiscal year
For the fiscal year
ended March 31, 2024
ended March 31, 2025
Income taxes - current
1,785
2,440
Income taxes - deferred
(128)
(366)
Total income taxes
1,657
2,073
Profit
3,434
4,783
Profit attributable to non-controlling interests
-
-
Profit attributable to owners of parent
3,434
4,783
Consolidated Statements of Comprehensive Income
(Millions of yen)
For the fiscal year
For the fiscal year
ended March 31, 2024
ended March 31, 2025
Profit
3,434
4,783
Other comprehensive income
Valuation difference on available-for-sale securities
310
(1,539)
Foreign currency translation adjustment
400
(88)
Remeasurements of defined benefit plans, net of tax
261
215
Share of other comprehensive income of entities
accounted for using equity method
125
(52)
Total other comprehensive income
1,097
(1,465)
Comprehensive income
4,531
3,318
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
4,531 3,318
Comprehensive income attributable to non-controlling
interests
-
-
Consolidated Statements of Changes in Equity
For the fiscal year ended March 31, 2024
(Millions of yen)
Shareholders' equity | |||||
Share capital | Capital surplus | Retained earnings | Treasury shares | Total shareholders' equity | |
Balance at beginning of period | 6,270 | 4,625 | 30,566 | (45) | 41,416 |
Changes during period | |||||
Dividends of surplus | (1,129) | (1,129) | |||
Profit attributable to owners of parent | 3,434 | 3,434 | |||
Purchase of treasury shares | (0) | (0) | |||
Net changes in items other than shareholders' equity | |||||
Total changes during period | - | - | 2,305 | (0) | 2,305 |
Balance at end of period | 6,270 | 4,625 | 32,871 | (45) | 43,722 |
Accumulated other comprehensive income | Total net assets | ||||
Valuation difference on available-for-sale securities | Foreign currency translation adjustment | Remeasurements of defined benefit plans | Total accumulated other comprehensive income | ||
Balance at beginning of period | 4,381 | 230 | 217 | 4,828 | 46,245 |
Changes during period | |||||
Dividends of surplus | (1,129) | ||||
Profit attributable to owners of parent | 3,434 | ||||
Purchase of treasury shares | (0) | ||||
Net changes in items other than shareholders' equity | 310 | 525 | 261 | 1,097 | 1,097 |
Total changes during period | 310 | 525 | 261 | 1,097 | 3,402 |
Balance at end of period | 4,691 | 755 | 478 | 5,925 | 49,647 |
For the fiscal year ended March 31, 2025
(Millions of yen)
Shareholders' equity | |||||
Share capital | Capital surplus | Retained earnings | Treasury shares | Total shareholders' equity | |
Balance at beginning of period | 6,270 | 4,625 | 32,871 | (45) | 43,722 |
Changes during period | |||||
Dividends of surplus | (1,254) | (1,254) | |||
Profit attributable to owners of parent | 4,783 | 4,783 | |||
Purchase of treasury shares | (0) | (0) | |||
Net changes in items other than shareholders' equity | |||||
Total changes during period | - | - | 3,529 | (0) | 3,529 |
Balance at end of period | 6,270 | 4,625 | 36,400 | (45) | 47,251 |
Accumulated other comprehensive income | Total net assets | ||||
Valuation difference on available-for-sale securities | Foreign currency translation adjustment | Remeasurements of defined benefit plans | Total accumulated other comprehensive income | ||
Balance at beginning of period | 4,691 | 755 | 478 | 5,925 | 49,647 |
Changes during period | |||||
Dividends of surplus | (1,254) | ||||
Profit attributable to owners of parent | 4,783 | ||||
Purchase of treasury shares | (0) | ||||
Net changes in items other than shareholders' equity | (1,539) | (141) | 215 | (1,465) | (1,465) |
Total changes during period | (1,539) | (141) | 215 | (1,465) | 2,063 |
Balance at end of period | 3,152 | 614 | 693 | 4,460 | 51,711 |
(4) Consolidated Statements of Cash Flows | ||
(Millions of yen) | ||
For the fiscal year ended March 31, 2024 | For the fiscal year ended March 31, 2025 | |
Cash flows from operating activities | ||
Profit before income taxes | 5,092 | 6,857 |
Depreciation | 1,872 | 1,925 |
Impairment losses | - | 29 |
Increase (decrease) in allowance for doubtful accounts | (0) | 0 |
Increase (decrease) in retirement benefit liability | 143 | (74) |
Loss (gain) on sale and retirement of non-current 23 3 assets | ||
Loss (gain) on sale of investment securities | (1,855) | (251) |
Share of loss (profit) of entities accounted for using equity method | (348) | (466) |
Interest and dividend income | (261) | (266) |
Interest expenses | 142 | 276 |
Decrease (increase) in trade receivables | (5,579) | 740 |
Decrease (increase) in inventories | (6,317) | (156) |
Increase (decrease) in trade payables | (1,454) | (3,165) |
Increase (decrease) in contract liabilities | 3,110 | (363) |
Other, net | 252 | 693 |
Subtotal | (5,179) | 5,781 |
Interest and dividends received | 268 | 280 |
Interest paid | (124) | (267) |
Income taxes paid | (869) | (2,050) |
Net cash provided by (used in) operating activities | (5,905) | 3,743 |
Cash flows from investing activities | ||
Payments into time deposits | (1,514) | (1,353) |
Proceeds from withdrawal of time deposits | 1,232 | 1,622 |
Purchase of investment securities | (23) | (19) |
Proceeds from sale of investment securities | 2,920 | 376 |
Purchase of property, plant and equipment | (828) | (958) |
Proceeds from sale of property, plant and equipment | 1 | 3 |
Purchase of intangible assets | (96) | (44) |
Other, net | 26 | 57 |
Net cash provided by (used in) investing activities | 1,717 | (317) |
Cash flows from financing activities | ||
Net increase (decrease) in short-term borrowings | 6,015 | (5,300) |
Proceeds from long-term borrowings | 5,000 | 10,000 |
Repayments of long-term borrowings | (2,283) | (7,700) |
Dividends paid | (1,129) | (1,254) |
Other, net | (195) | (197) |
Net cash provided by (used in) financing activities | 7,407 | (4,452) |
Effect of exchange rate change on cash and cash equivalents | 270 | (24) |
Net increase (decrease) in cash and cash equivalents | 3,490 | (1,051) |
Cash and cash equivalents at beginning of period | 5,693 | 9,183 |
Cash and cash equivalents at end of period | 9,183 | 8,132 |
